Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size will reach 2,457.18 Million USD in 2025 and is projected to reach 2,143.83 Million USD by 2032, with a CAGR of -1.93% (2025-2032). Notably, the China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Chemotherapy-induced nausea and vomiting (CINV) drugs are medications specifically designed to prevent or alleviate the symptoms of nausea and vomiting caused by chemotherapy treatments. Chemotherapy, a common cancer treatment, can trigger the release of certain chemicals in the body that stimulate the vomiting center in the brain, leading to CINV in many patients. CINV drugs work by targeting receptors in the brain and gastrointestinal tract, suppressing the signals that trigger nausea and vomiting. These drugs can be given before, during, or after chemotherapy sessions, and they are essential in improving the quality of life for cancer patients by reducing the distressing side effects associated with chemotherapy. CINV drugs are available in various forms, including oral tablets, injections, and patches, and their use is determined based on the individual patient's condition, the type of chemotherapy regimen, and the risk of developing CINV. Effective management of CINV is crucial to support cancer patients throughout their treatment and help them complete their therapy successfully.
The major global suppliers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Include:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Segment Include:
5-HT3 Inhibitors
NK1 Inhibitors
Others
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Application Include:
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry PESTEL Analysis
Chapter 3: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size will reach 2,457.18 Million USD in 2025 and is projected to reach 2,143.83 Million USD by 2032, with a CAGR of -1.93% (2025-2032). Notably, the China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Chemotherapy-induced nausea and vomiting (CINV) drugs are medications specifically designed to prevent or alleviate the symptoms of nausea and vomiting caused by chemotherapy treatments. Chemotherapy, a common cancer treatment, can trigger the release of certain chemicals in the body that stimulate the vomiting center in the brain, leading to CINV in many patients. CINV drugs work by targeting receptors in the brain and gastrointestinal tract, suppressing the signals that trigger nausea and vomiting. These drugs can be given before, during, or after chemotherapy sessions, and they are essential in improving the quality of life for cancer patients by reducing the distressing side effects associated with chemotherapy. CINV drugs are available in various forms, including oral tablets, injections, and patches, and their use is determined based on the individual patient's condition, the type of chemotherapy regimen, and the risk of developing CINV. Effective management of CINV is crucial to support cancer patients throughout their treatment and help them complete their therapy successfully.
The major global suppliers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Include:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Segment Include:
5-HT3 Inhibitors
NK1 Inhibitors
Others
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Application Include:
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry PESTEL Analysis
Chapter 3: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product by Type
- 1.2.1 5-HT3 Inhibitors
- 1.2.2 NK1 Inhibitors
- 1.2.3 Others
- 1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product by Application
- 1.3.1 Acute CINV
- 1.3.2 Delayed CINV
- 1.3.3 Breakthrough CINV
- 1.3.4 Others
- 1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Analysis (2020-2032)
- 1.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Development Status and Trends
- 1.5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Development Status Analysis
- 1.5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Development Trends Analysis
- 2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Analysis by Country
- 4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.5 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.6 France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.14 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue by Key Suppliers (2021-2025)
- 5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Analysis by Type
- 6.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Heron Therapeutics
- 7.1.1 Heron Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Merck
- 7.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Eisai
- 7.3.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Mundipharma
- 7.4.1 Mundipharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Qilu Pharma
- 7.5.1 Qilu Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Teva
- 7.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Novartis
- 7.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Roche
- 7.8.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Mylan
- 7.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Baxter
- 7.10.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 GSK
- 7.11.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Helsinn
- 7.12.1 Helsinn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Southwest Pharma
- 7.13.1 Southwest Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Haisco
- 7.14.1 Haisco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Sun Pharma
- 7.15.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
- 7.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis
- 8.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Downstream Application Analysis
- 8.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Forecast by Application (2020-2032)
- 8.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Downstream Customers
- 8.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
